78 evolution "https:" "https:" "https:" "https:" "https:" "https:" "The University of Manchester" uni jobs at Ghent University in Belgium
Sort by
Refine Your Search
-
setups in which research results can be implemented and evaluated Contributing to the development and writing of new research and project proposals (e.g. FWO, SBO, VLAIO, Horizon Europe, Internal Security
-
Department PS05 - Department of Conflict and Development Studies Degree Masters Diploma Occupancy rate 100% Vacancy type Research staff ABOUT GHENT UNIVERSITY The Conflict Research Group (CRG) , based
-
, United Nations University, ...).https://www.ugent.be/en/research/funding/globalsouthhttps://www.ugent.be/++resource++plone-logo.svg Ghent University actively participates in several development projects, financed
-
the internal and external services of the department WHAT WE ARE LOOKING FOR You hold a degree of Master of Medicine in Medicine, Master of Science in Hospital Pharmacy, Pharmaceutical Care, Drug Development
-
hold a degree of Master of Medicine in Medicine, Master of Science in Hospital Pharmacy, Pharmaceutical Care, Drug Development or equivalent degree. The degree requirement needs to be fulfilled
-
of rheumatoid arthritis pathogenesis. Our team has a longstanding interest in external risk factors for arthritis development (PMID: 32080619), in which we have demonstrated that mechanical loading of the joints
-
evolution of life from ancient Palaeozoic times to the current Anthropocene. The group currently includes a motivated cohort of PhD students, MSc students and postdocs working on various aspects of (micro
-
knowledge and techniques, apply them and distribute them to this end. Depending on the candidate, one can also participate in the development of new methodology in function of the application. Our
-
, process modelling, process support) and Geert Poels (e.g., business architecture, business ecosystem modelling, system-of-systems governance, capability-based management) (https://ugent
-
Commission will focus on further development of innovative health biotechnological drugs, more specifically mRNA therapeutics. As the science and knowledge service of the European Commission, the Joint